to secrete tumor necrosis factor-α (TNFα) and interleukin-6 (IL6), which resulted in loss of PVAT's anticontractile function. In rat mesenteric arteries, these inflammatory cytokines impaired the anticontractile activity of healthy PVAT, 22 and in mouse femoral arteries, endovascular injury upregulated inflammation in PVAT. 23 Thus, the progression of the inflammatory reaction in PVAT seems to be crucial in altering PVAT's vasoactive properties; however, intracellular mechanisms that might control these reactions are not known. Recently, mTORC2-deficient mouse embryonic fibroblasts and rictor knockdown of dendritic cells exhibited a hyperinflammatory phenotype after lipopolysaccharide stimulation. 24 In the present study, we have, therefore, tested the hypothesis that deletion of rictor in adipose tissue, and thereby inactivation of mTORC2 in PVAT, may modulate vascular function by increasing inflammation in PVAT.
Materials and Methods
Materials and Methods are available in the online-only Supplement.
Results

Adipose-Specific Deletion of Rictor Attenuates mTORC2 Signaling in Aortic PVAT
To analyze the role of mTORC2 in PVAT for vascular function, we used adipose cell-specific rictor knockout ( rictor ad−/− ) and corresponding control (rictor fl/fl ) mice, which were described previously. 10 Adipose-specific rictor knockout was confirmed by significant reduction of rictor gene expression in epididymal fat (EFAT) from rictor ad−/− mice ( Figure I in the online-only Data Supplement). Next, rictor gene expression in aorta (tissue containing mainly smooth muscle and endothelial cells) and in PVAT surrounding the thoracic aorta (referred henceforth as PVAT) was examined. The expression of rictor was significantly reduced in the PVAT but remained unchanged in the aorta from rictor ad−/− mice ( Figure 1A ). To evaluate mTORC2 activity, aortic rings with intact PVAT were stimulated with insulin. Subsequently, PVAT and aorta were separated and analyzed for Akt Ser473 phosphorylation, a known TORC2 substrate. 8 PVAT from rictor ad−/− mice exhibited reduced Akt Ser473 phosphorylation after insulin stimulation indicating impaired insulin signaling ( Figure 1B  and 1C ). In the aorta, insulin-induced Akt Ser473 phosphorylation remained unchanged in the groups ( Figure 1B and 1C) . No difference was detected in insulin-stimulated phosphorylation of extracellular signal-regulated protein kinase 1 and 2 between the mice groups in PVAT and aorta ( Figure 1B ).
Increased Aortic Contraction and Impaired Endothelium-Dependent Relaxation in Rictor ad−/− Mice in the Presence of PVAT
PVAT surrounding the arteries influences vascular function. 12, 13 To investigate whether adipose-specific rictor deletion modulate aortic contractions, aortic rings with or without PVAT were used. To test the contractile capacity of the smooth muscle cell layer by direct depolarization, all rings were initially treated with 100 mmol/L potassium chloride (KCl). In all rings, similar contractions independent of rictor and PVAT were observed (data not shown). Next, we investigated the contribution of rictor in PVAT to receptor-dependent vascular contraction. Aortic rings with or without PVAT were exposed to vasoconstrictor phenylephrine (PE) in a concentration-dependent manner. Aortic rings with PVAT from rictor ad−/− mice displayed 2.1-fold higher maximal contractions as compared with rings from rictor fl/fl mice after treatment with PE (rictor ad−/− : 43.2±6.3% versus rictor fl/fl : 20.1±3.8% at 3×10 −6 mol/L; Figure 2A ). With the removal of PVAT, contractions to PE increased overall and maximal contractions were not significantly different between both groups of mice (rictor ad−/− : 70.0±8.6% versus rictor fl/fl : 81.0±10.1% at 3×10 −6 mol/L; Figure 2B ). To determine whether vascular relaxation was also affected, we analyzed acetylcholine-induced endothelium-dependent relaxation. Acetylcholine-induced relaxation in aortic rings with PVAT was impaired in rictor ad−/− mice ( Figure 2C ). This impairment was also confirmed by the pD 2 values, which suggests a delay in relaxation in rictor ad−/− aortic rings with PVAT (rictor ad−/− : 6.2±0.2 mol/L versus rictor fl/fl : 7.0±0.1 mol/L). On removal of PVAT, the differences were lost and the aortic rings relaxed normally ( Figure 2D ). As we found differences in contraction and dilation to receptor-dependent agonists in rings with PVAT, we further characterized contraction to KCl. Concentration-dependent (10-100 mmol/L) KCl-induced contractions in aortic rings with PVAT were similar between both groups of mice ( Figure  II in the online-only Data Supplement). Hypothetically, increased aortic contraction with PVAT in rictor ad−/− mice might be because of reduced nitric oxide (NO) availability. To investigate this, we used N G -nitro-L-arginine methyl ester (L-NAME) which preferentially inhibits endothelial nitric oxide synthase (eNOS). 25 In the presence of L-NAME (300×10 −6 mol/L), the contractile responses to PE increased in rings with PVAT from both mice groups ( Figure 2E ). Nonetheless, PE-induced contractions were higher in aortic rings with PVAT from rictor ad−/− mice (1.5-fold; rictor ad−/− : 86.36±8.17% versus rictor fl/fl : 58.78±6.71% at 3×10 −6 mol/L; Figure 2E ).
To define the specificity of L-NAME for the different NO synthases, we used RAW264.7 cell line which exclusively expresses inducible NOS (iNOS/NOS2). 26 NO measurements after lipopolysaccharide stimulation revealed that L-NAME at 300×10 −6 mol/L also partially inhibited iNOS-induced NO production (≈40%; Figure III in the online-only Data Supplement). These results suggest that L-NAME is a nonselective NOS inhibitor. Expectedly, iNOS inhibitor 1400 W (10 −6 mol/L), a highly specific and selective inhibitor, 27 inhibited lipopolysaccharide-induced NO production to baseline levels ( Figure III in the online-only Data Supplement).
In addition to NO, endothelium also releases other dilatory factors. Hence, experiments were performed with endothelium-denuded aortic rings with PVAT. Aortic contractions to PE or prostaglandin F 2α were significantly higher in rictor ad−/− mice compared with rictor fl/fl mice ( Figure 2F and 2G). Taken together, these results suggest that the anticontractile effect mediated by rictor is for the most part endothelium-independent.
Loss of Rictor in Adipose Cells of PVAT Results in Upregulation of Inflammatory Mediators
To determine how loss of rictor in adipose cells of PVAT increases aortic contractions and impairs relaxation, we screened genes which are expressed in and secreted by PVAT. These included adipokines, 28 reactive oxygen species, 17, 29 and inflammatory molecules. 30 Among the adipokines, gene expression levels of adiponectin (adipoq) and lipocalin (lnc2) were not affected in the PVAT from rictor ad−/− mice ( Figure 3A ). However, the expression level of resistin (retn) was significantly reduced. Gene expression of NADPH oxidase subunits nox2, nox4, p22phox, and p67phox and adipocyte markers (Pparg and Fabp4) were not affected. Interestingly, the expression of inflammatory genes, such as 
Increased iNOS Expression but Unchanged Leukocytes Levels in PVAT from Rictor ad−/− Mice
To investigate whether the augmented expression of inflammatory molecules was associated with elevated macrophage infiltration in PVAT, we determined steady-state mRNA expression levels of macrophage-associated genes emr1 (F4/80), CD163, and Nos2/iNos. Expression of F4/80 and CD163 was similar between groups, whereas iNos expression increased significantly in PVAT from rictor ad−/− mice ( Figure 4A ). To validate this, we examined the expression of iNOS in cross sections of thoracic aorta with PVAT. Indeed, iNOS expression was higher in the PVAT from rictor ad−/− mice ( Figure 4B ). The uniform expression of iNOS across the PVAT suggests that adipocytes themselves and not macrophages are the predominant cells expressing iNOS. Moreover, iNOS staining in aortic medial layer was hardly visible.
Using flow cytometry, the infiltration of inflammatory cells was quantified. The percentages of total leukocytes and macrophages in the stromal vascular fractions were similar between groups in PVAT ( Figure 4C ). In EFAT, no differences in leukocyte and macrophage percentages in stromal vascular fractions were detected, but overall percentages of leukocytes and macrophages were increased ≈100% when compared with PVAT ( Figure 4C ).
Inhibition of iNOS Restores Anticontractile Effect of PVAT
We analyzed the effect of TNFα on PE-induced contractions, as this proinflammatory cytokine has been shown to counteract the anticontractile activity of PVAT. 22 In aortic rings with PVAT from rictor fl/fl mice, contractions to PE (10 −6 mol/L) increased in the presence TNFα but not to a similar level as contractions in the rings from rictor ad−/− mice, which were significantly higher compared with untreated rings from rictor fl/fl mice ( Figure IV in the online-only Data Supplement). TNFα stimulated iNos expression in 3T3-L1 adipocytes ( Figure V in the online-only Data Supplement) as reported previously. 31 To confirm our observation that iNOS is expressed mainly in PVAT ( Figure 4B , only background staining in the medial layer of the aorta), we analyzed gene expression of iNos in aortic tissue and PVAT. Indeed, expression of iNos was only detected in PVAT but not in the aorta of rictor ad−/− mice using quantitative real-time polymerase chain reaction (cycle threshold value in PVAT: 29; aorta: no amplification). Thus, we investigated the possible role of iNOS for vascular function using iNOS inhibitor 1400 W. 27 In aortic rings with PVAT, contractions in rictor ad−/− mice were reduced in the presence of 1400 W ( Figure 5A ), reaching similar levels detected in rictor fl/fl mice ( Figure 5B ). In addition, treatment with 1400 W improved the endothelium-dependent relaxation in aortic rings with PVAT from rictor ad−/− mice ( Figure 5C ) to comparable levels observed in control rings ( Figure 5D ). Thus, the altered function in aortic rings with PVAT in rictor ad−/− mice was normalized after inhibition of iNOS. Taken together, our 
Downregulation of Rictor Expression in Adipose Tissue After High-Fat Diet Feeding
Because depletion of rictor in adipose tissue is associated with increased expression of inflammatory genes and proteins in PVAT, we assessed the possible physiological relevance of rictor expressional regulation after high-fat diet (HFD) feeding, a model of experimental obesity and chronic low-grade inflammatory disease. 32 We analyzed rictor gene expression levels in PVAT and EFAT in control mice fed for 10 to 12 weeks with a HFD and with control diet. Steady-state mRNA expression levels of rictor were significantly downregulated in both types of adipose tissue after HFD (>30%; Figure 6A and 6B, left panels). Concomitantly, iNos expression was significantly increased in PVAT of these HFD fed mice, whereas in EFAT only an upward trend was observed (P=0.16). In June 2013, a search in published micro array data sets in NCBI Gene Expression Omnibus database 33 revealed that rictor mRNA expression levels were also significantly lower in white adipose tissue from C57Bl6/J mice after 8 weeks of HFD feeding (accession number GSE30247; Figure VI in the online-only Data Supplement), whereas inflammatory genes were upregulated. 34 
Discussion
In the present study, we describe a hitherto unknown function of the serine and threonine kinase complex mTORC2 in controlling the anticontractile activity of PVAT primarily by regulating inflammation in the adipocytes. Downregulation of rictor, an essential mTORC2 component, in adipose tissue increased gene expression of Tnfα, Mip1α, and iNos in PVAT and, concurrently increased the secretion of IL6, MIP1α, and TNFα. Moreover, inhibition of iNOS restored the anticontractile activity of PVAT lacking rictor. Importantly, we demonstrate that in a model of low-grade chronic inflammation, such as HFD-induced obesity, gene expression of rictor in PVAT is downregulated, whereas that of iNos is upregulated.
Studies addressing PVAT's contribution to vascular functions have largely focused on identifying molecules released by PVAT in normal and in pathophysiological conditions, such as obesity or hypertension. 13, 30 Signaling enzymes in PVAT that control the expression and secretion of these secretory molecules are not yet known. To the best of our knowledge, this is the first study to show the contribution of an intracellular signaling molecule (rictor) in adipocytes of PVAT in regulating the anticontractile activity.
Jabs et al 35 have shown that continuous treatment with the mTOR inhibitor rapamycin, also known as sirolimus, markedly reduced vasorelaxation to acetylcholine in rat aortae devoid of PVAT by inducing endothelial dysfunction associated with reduced NO availability. Possible underlying mechanism may be the direct inhibition of mTORC1. In endothelial cells, however, also mTORC2 assembly after long-term rapamycin treatment is compromised, 36 impairing downstream signaling from Akt to endothelial NOS. 37, 38 In our study, depletion of rictor from adipose cells in PVAT increased aortic contractions in response to receptor-dependent vasoconstrictors and impaired vasorelaxation. On removing PVAT, the differences in contraction and dilation between the mice groups vanished, supporting the current model stating that PVAT-released molecules directly mediate vasoactive effects. 13 PVAT can exert its anticontractile effects via endotheliumdependent or endothelium-independent mechanisms. 17, 20 The endothelium-dependent effect involves production of NO by endothelial NOS, which is required to maintain vascular tone, regulate platelet aggregation and leukocyte adhesion. 39 In our model, the anticontractile function of PVAT was still compromised after endothelium denudation in rictor ad−/− mice compared with controls. Thus, endothelium-derived vasodilators do not play a major role in anticontractile effects mediated by mTORC2 in PVAT. Inherent contractile responsiveness of vascular smooth muscle cells in the aortic rings was also preserved, despite the loss of rictor in PVAT because KCl-induced contractions were identical. This suggests that anticontractile effects mediated via mTORC2 in PVAT are most likely caused by modulation of the secretory proteins affecting adjacent vascular cells without changing their inherent functionality.
Increased inflammation and oxidative stress in PVAT have been linked to promote vasoconstriction and endothelial dysfunction. 40, 41 In this regard, we screened the expression of reactive oxygen species, generating NADPH oxidase subunits and inflammatory cytokines. In PVAT lacking rictor, expression levels of iNos and inflammatory cytokines, such as IL6, MIP1α, and TNFα, were increased. Thus, in murine PVAT, decreased mTORC2 activity initiated a cascade of inflammatory pathways.
Vascular expression of iNOS occurs during pathological changes in the vascular wall such as atherosclerosis development, hypertension, and vascular injury. 42 These pathologies are often associated with inflammatory processes which induce expression of iNOS in the vascular wall. Healthy blood vessels do not express iNOS. 43 Consistent with this finding, we did not detect iNOS expression in thoracic arterial tissue, that is, endothelium plus vascular smooth muscle cells, without PVAT. Tian et al 44 have demonstrated that inhibition of iNOS protects endothelium/NO-dependent vasodilation of thoracic aorta in aged rats. Vice versa, overexpression of iNOS using gene transfer resulted in impaired NO-dependent vasorelaxation in carotid arteries. 45 In our work, partial inhibition of iNOS by 40% using nonselective NOS inhibitor L-NAME was not sufficient to adjust PE-mediated contractions between groups, whereas specific and complete inhibition of iNOS using 1400 W completely restored vasodilation and anticontractile activity in rings with PVAT lacking adipose-specific rictor. We propose that PVAT from rictor ad−/− mice has preserved vasodilator effects which are compromised by the action of upregulated procontractile mediators such as iNOS-derived NO metabolites and proinflammatory cytokines. As a consequence, the procontractile molecules counteract but cannot abolish the overall anticontractile activity exerted, which is ultimately lost only after removal of PVAT in rings from rictor ad−/− mice.
The marked reduction in insulin-stimulated Akt phosphorylation in PVAT of rictor ad−/− mice may not only be caused by reduced mTORC2 to Akt signaling but may also be attributed to insulin resistance in these mice, 10, 11 resulting in impaired insulin signaling already at the level of the insulin receptor substrates. 46 Brown et al 24 have demonstrated that expression of a constitutively active Akt variant normalizes the hyperinflammatory phenotype in rictor-deficient cells by restoring mTORC2 downstream signaling. Thus, these increased inflammatory expression profiles observed in our study may possibly be caused by defective Akt signaling in PVAT lacking rictor.
Infiltration of macrophages and T cells in PVAT has been reported in mice fed with HFD. 28, 30 In contrast, thoracic PVAT has also been reported to be fairly resistant to macrophage infiltration, to obesity-induced inflammation, and is nearly identical to interscapular brown adipose tissue. 47 In line with these findings, we found in our study about half as many leukocytes and macrophages in vascular stromal fractions of PVAT as compared with those of EFAT. These observations argue against an intrinsically proinflammatory depot in thoracic PVAT. Moreover, there was no difference in macrophage presence in PVAT between rictor fl/fl and rictor ad−/− mice. Thus, we suggest that ablation of rictor in adipocytes initiates expressional changes to upregulate release of inflammatory molecules in the adipocyte itself which counteract PVAT's anticontractile function.
The hyperinflammatory phenotype in PVAT caused by rictor deletion in adipocytes resembles obesity-induced changes. 22, 48, 49 Increased expression of inflammatory cytokines, such as TNFα and IL6 in PVAT of obese patients, has been implicated to reduce its anticontractile activity. 22 In line, a previous study by Meijer et al 50 showed that inhibition of inflammation restored anticontractile function of microvascular PVAT in a genetic model of obesity.
Intriguingly in our study, experimental obesity in mice induced via HFD feeding per se downregulated expression of rictor in thoracic PVAT, whereas iNos expression was upregulated. Considering the complexity and the interplay of different molecules and cells involved in obesity-induced adipose tissue inflammation, it was beyond the scope of the present study to elucidate mechanisms underlying the downregulation of rictor expression in this context. We speculate that several inflammatory molecules, including TNFα, induce a series of signaling cascades in perivascular adipocytes resulting in downregulation of rictor expression. Furthermore, reduced mTORC2 assembly and signaling, in turn, might further advance the ongoing inflammatory response. Thus, mTORC2 signaling is highly likely to participate in the complex regulation of obesity-associated adipose tissue inflammation.
In conclusion, the present findings assign a decisive function to rictor in PVAT in protecting arteries from inflammatory stress and in controlling normal vascular function. Stabilizing expression of rictor in adipose tissue during obesity and other metabolic rearrangements might, therefore, embody a novel treatment approach to combat inflammation-associated vascular damage.
